Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis

British Journal of Pharmacology

Volumn 158, Issue 6, 2009, Pages 1565-1578

  Módis, Katalin ^a   Gero, Domokos ^a   Nagy, Nóra ^a   Szoleczky, Petra ^a   Tóth, Zoltán Dóri ^a   Szabó, Csaba ^a,b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Adenosine; Adenosine receptors; High throughput screening; Hypoxia; Inosine; Ischaemia; Kidney; Metabolism; Reperfusion injury

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 6 ETHYL 2 PHENYL 4 PROPYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE KINASE; ADENOSINE TRIPHOSPHATE; INOSINE; LACTATE DEHYDROGENASE;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; HYPOXIA; KIDNEY TUBULE CELL; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; CELL DEATH; CELL HYPOXIA; CYTOPROTECTION; EPITHELIAL CELLS; GLUCOSE; INOSINE; KIDNEY TUBULAR NECROSIS, ACUTE; KIDNEY TUBULES; L-LACTATE DEHYDROGENASE; MITOCHONDRIA; OXYGEN; RATS; RECEPTORS, PURINERGIC P1;

EID: 70350538713     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00432.x     Document Type: Article

References (63)

1. Advani A, Gilbert RE, Thai K, Gow RM, Langham RG, Cox AJ et al. (2009). Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J Am Soc Nephrol 20 : 730 741.
2. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC) 3rd edn. Br J Pharmacol 153 : S1 S209.
3. Beach RE, Watts BA 3rd., Good DW, Benedict CR, DuBose TD Jr. (1991). Effects of graded oxygen tension on adenosine release by renal medullary and thick ascending limb suspensions. Kidney Int 39 : 836 842.
4. Bruns RF, Fergus JH, Badger EW, Bristol JA, Santay LA, Hartman JD et al. (1987). Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3- dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch Pharmacol 335 : 59 63.
5. Butcher EC (2005). Can cell systems biology rescue drug discovery? Nat Rev Drug Dis 4 : 461 467.
6. Chatterjee PK (2007). Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 376 : 1 43.
7. Chatterjee PK, Thiemermann C (2003). Emerging drugs for renal failure. Expert Opin Emerg Drugs 8 : 389 435.
8. Chen S, Zhang Q, Wu X, Schultz PG, Ding S (2004). Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 126 : 410 411.
9. Day YJ, Huang L, McDuffie MJ, Rosin DL, Ye H, Chen JF et al. (2003). Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest 112 : 883 891.
10. Day YJ, Huang L, Ye H, Linden J, Okusa MD (2005). Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol 288 : F722 F731.
11. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N et al. (2005). Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1 : 112 119.
12. Di Sole F, Cerull R, Babich V, Casavola V, Helmle-Roth C, Burckhardt G (2008). Short- and long-term A3 adenosine receptor activation inhibits the Na+/H+ exchanger NHE3 activity and expression in opossum kidney cells. J Cell Physiol 216 : 221 233.
13. Dishart MK, Kellum JA (2000). An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure. Drugs 59 : 79 91.
14. Edelstein CL, Ling H, Wangsiripaisan A, Schrier RW (1997). Emerging therapies for acute renal failure. Am J Kidney Dis 30 : S89 S95.
15. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schonfeld C et al. (2005). HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202 : 1493 1505.
16. Gallos G, Ruyle TD, Emala CW, Lee HT (2005). A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis. Am J Physiol Renal Physiol 289 : F369 F376.
17. Gero D, Modis K, Nagy N, Szoleczky P, Toth ZD, Dorman G et al. (2007). Oxidant-induced cardiomyocyte injury: Identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay. Int J Mol Med 20 : 749 761.
18. Grenz A, Zhang H, Eckle T, Mittelbronn M, Wehrmann M, Kohle C et al. (2007a). Protective role of ecto-5′-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol 18 : 833 845.
19. Grenz A, Zhang H, Hermes M, Eckle T, Klingel K, Huang DY et al. (2007b). Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J 21 : 2863 2873.
20. 2B Adenosine Receptor Protects the Kidney from Ischemia. PLoS Medicine 5 : e137.
21. Hasko G, Sitkovsky MV, Szabo C (2004). Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 25 : 152 157.
22. Haun SE, Segeleon JE, Trapp VL, Clotz MA, Horrocks LA (1996). Inosine mediates the protective effect of adenosine in rat astrocyte cultures subjected to combined glucose-oxygen deprivation. J Neurochem 67 : 2051 2059.
23. Jackson EK, Zacharia LC, Zhang M, Gillespie DG, Zhu C, Dubey RK (2006). cAMP-adenosine pathway in the proximal tubule. J Pharmacol Exp Ther 317 : 1219 1229.
24. Jagtap P, Soriano FG, Virag L, Liaudet L, Mabley J, Szabo E et al. (2002). Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med 30 : 1071 1082.
25. Jarvis MF, Yu H, Kohlhaas K, Alexander K, Lee CH, Jiang M et al. (2000). ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse. J Pharmacol Exp Ther 295 : 1156 1164. (Pubitemid 30951576)
26. Joo JD, Kim KM, D'Agati VD, Lee HT (2006). Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice. J Am Soc Nephrol 17 : 3115 3123.
27. Joo JD, Kim M, Horst P, Kim J, D'Agati VD, Emala CW Sr. et al. (2007). Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors. Am J Physiol Renal Physiol 293 : F1847 F1857.
28. Jurkowitz MS, Litsky ML, Browning MJ, Hohl CM (1998). Adenosine, inosine, and guanosine protect glial cells during glucose deprivation and mitochondrial inhibition: correlation between protection and ATP preservation. J Neurochem 71 : 535 548.
29. Kowaluk EA, Mikusa J, Wismer CT, Zhu CZ, Schweitzer E, Lynch JJ et al. (2000). ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. J Pharmacol Exp Ther 295 : 1165 1174.
30. Lee HT (2002). Preconditioning and Adenosine Protect Human proximal Tubule Cells in an In Vitro Model of Ischemic Injury. J Am Soc Nephrol 13 : 2753 2761.
31. Lee HT, Emala CW (2000). Protective effects of renal ischemic preconditioning and adenosine pretreatment: Role of A(1) and A(3) receptors. AM J Physiol Renal Physiol 278 : F380 F387.
32. Lee HT, Emala CW (2001). Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation. Am J Kidney Dis 38 : 610 618.
33. Lee HT, Emala CW (2002a). Adenosine attenuates oxidant injury in human proximal tubular cells via A(1) and A(2a) adenosine receptors. Am J Physiol Renal Physiol 282 : F844 F852.
34. Lee HT, Emala CW (2002b). Characterization of adenosine receptors in human kidney proximal tubule (HK-2) cells. Exp Nephrol 10 : 383 392.
35. Lee HT, Ota-Setlik A, Xu H, D'Agati VD, Jacobson MA, Emala CW (2003). A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure. Am J Physiol Renal Physiol 284 : F267 F273.
36. Lee HT, Xu H, Nasr SH, Schnermann J, Emala CW (2004). A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am J Physiol Renal Physiol 286 : F298 F306.
37. Li FZ, Kimura S, Nishiyama A, Rahman M, Zhang GX, Abe Y (2005). Ischemic preconditioning protects post-ischemic renal function in anesthetized dogs: role of adenosine and adenine nucleotides. Acta Pharmacol Sin 26 : 851 859.
38. Lien YH, Lai LW, Silva AL (2003). Pathogenesis of renal ischemia/reperfusion injury: lessons from knockout mice. Life Sci 74 : 543 552.
39. Litsky ML, Hohl CM, Lucas JH, Jurkowitz MS (1999). Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during chemical hypoxia. Brain Res 821 : 426 432.
40. Mandel JL, Takano T, Soltoff SP, Murdaugh S (1998). Mechanisms whereby exogenous adenine nucleotides improve rabbit renal proximal function during and after anoxia. J Clin Invest 81 : 1255 1264.
41. Milano PM, Douillet CD, Riesenman PJ, Robinson WP 3rd., Beidler SK, Zarzaur BL et al. (2008). Intestinal ischemia-reperfusion injury alters purinergic receptor expression in clinically relevant extraintestinal organs. J Surg Res 145 : 272 278.
42. Nishiyama A, He KS, Miura H, Rahman K, Fujisawa M, Fukui Y et al. (2001). Renal interstitial adenosine metabolism during ischemia in dogs. Am J Physiol Renal Physiol 280 : F231 F238.
43. Okusa MD (2002). A(2A) adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol Renal Physiol 282 : F10 F18.
44. Okusa MD, Linden J, Macdonald T, Huang L (1999). Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol 277 : F404 F412.
45. Okusa MD, Linden J, Huang L, Rieger JM, Macdonald TL, Huynh LP (2000). A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 279 : F809 F818.
46. Okusa MD, Linden J, Huang L, Rosin DL, Smith DF, Sullivan G (2001). Enhanced protection from renal ischemia-reperfusion injury with A(2A)-adenosine receptor activation and PDE 4 inhibition. Kidney Int 59 : 2114 2125.
47. Osswald H, Schmitz HJ, Kemper R (1977). Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation. Pflugers Arch 371 : 45 49.
48. Rose'Meyer RB, Harrison GJ, Headrick JP (2003). Enhanced adenosine A(2B) mediated coronary response in reserpinised rat heart. Naunyn Schmiedebergs Arch Pharmacol 367 : 266 273.
49. Rosen S, Stillman IE (2008). Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. J Am Soc Nephrol 19 : 871 875.
50. Sams-Dodd F (2005). Target-based drug discovery: is something wrong? Drug Discov Today 10 : 139 147.
51. Spedding M, Jay T, Costa e Silva J, Perret L (2005). A pathophysiological paradigm for the therapy of psychiatric disease. Nat Rev Drug Discov 4 : 467 476.
52. Spitsin S, Hooper DC, Leist T, Streletz LJ, Mikheeva T, Koprowskil H (2001). Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease. Multiple Sclerosis 7 : 313 319.
53. Sugino H, Shimada H, Tsuchimoto K (2001). Role of adenosine in renal protection induced by a brief episode of ischemic preconditioning in rats. Jpn J Pharmacol 87 : 134 142.
54. Szabo C (1996). The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 6 : 79 88.
55. Szabo G, Stumpf N, Radovits T, Sonnenberg K, Gero D, Hagl S et al. (2006). Effects of inosine on reperfusion injury after heart transplantation. Eur J Cardiothorac Surg 30 : 96 102.
56. Takeo S, Tanonaka K, Miyake K, Imago M (1988). Adenine nucleotide metabolites are beneficial for recovery of cardiac contractile force after hypoxia. J Mol Cell Cardiol 20 : 187 199. (Pubitemid 18128141)
57. Toth-Zsamboki E, Horvath E, Vargova K, Pankotai E, Murthy K, Zsengeller Z et al. (2006). Activation of poly (ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes. Mol Med 12 : 221 228.
58. Vallon V, Muhlbauer B, Osswald H (2006). Adenosine and kidney function. Physiol Rev 86 : 901 940.
59. Venkataraman R, Kellum JA (2000). Novel approaches to the treatment of acute renal failure. Expert Opin Investig Drugs 9 : 2579 2592.
60. Venkataraman R, Kellum JA (2003). Novel approaches to the treatment of acute renal failure. Expert Opin Investig Drugs 12 : 1353 1366.
61. Virag L, Szabo C (2001). Purines inhibit poly (ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB J 15 : 99 107.
62. Weinberg JM, Humes HD (1986). Increases of cell ATP produced by exogenous adenine nucleotides in isolated rabbit kidney tubules. Am J Physiol 250 : F720 33.
63. Xu Y, Shi Y, Ding S (2008). A chemical approach to stem-cell biology and regenerative medicine. Nature 453 : 338 344.